Here you will find financial news and reports from APONTIS PHARMA as well as other publications relevant to the capital market.

APONTIS PHARMA publications in detail and up to date

developAd-hoc-Releases

  • There are no current ad hoc releases available.

  • 2021‑05‑06 | DGAP-Ad-hoc

    APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share

    APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share 06-May-2021 / 20:07 CET/CEST Disclosure of a...

    Read more...

developCorporate News

  • There are no current corporate news available.

  • 2021‑12‑16 | DGAP-News

    APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO

    DGAP-News: APONTIS PHARMA AG / Key word(s): Personnel 16.12.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...

    Read more...
    2021‑12‑14 | DGAP-News

    APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-Euro...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch/Alliance 14.12.2021 / 07:30 The issuer is solely responsible for the content of this announ...

    Read more...
    2021‑11‑18 | DGAP-News

    APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Re...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement/9 Month figures 18.11.2021 / 07:30 The issuer is solely responsible for the ...

    Read more...
    2021‑10‑26 | DGAP-News

    APONTIS PHARMA announces market launch of new Single Pill

    DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 26.10.2021 / 07:30 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑09‑14 | DGAP-News

    APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and ...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 14.09.2021 / 07:30 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑08‑11 | DGAP-News

    APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figur...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report 11.08.2021 / 07:30 The issuer is solely responsible for the content of ...

    Read more...
    2021‑07‑28 | DGAP-News

    APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR 1...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Half Year Results 28.07.2021 / 07:30 The issuer is solely responsible for the content ...

    Read more...
    2021‑07‑12 | DGAP-News

    APONTIS PHARMA marks further success in the roll-out of Single Pill therapy

    DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 12.07.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...

    Read more...
    2021‑06‑18 | DGAP-News

    APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 1...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Research Update 18.06.2021 / 07:30 The issuer is solely responsible for the content of this announcement.<...

    Read more...
    2021‑06‑10 | DGAP-News

    APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:23 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑06‑10 | DGAP-News

    APONTIS PHARMA AG: Notification on the implementation of stabilization measures

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:20 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑05‑28 | DGAP-News

    APONTIS PHARMA AG: Notification on the implementation of stabilization measures

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 28.05.2021 / 20:05 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑05‑20 | DGAP-News

    APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues i...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement 20.05.2021 / 07:30 The issuer is solely responsible for the content of this ...

    Read more...
    2021‑05‑19 | DGAP-News

    APONTIS PHARMA AG: Notification on the implementation of stabilization measures

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 19.05.2021 / 20:23 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑05‑14 | EQS-News

    Apontis Pharma (APPH): Initiation - A phoenix rises

    Edison Investment Research Limited 14-May-2021 / 07:00 GMT/BST

    Read more...

developFinancial Reports

  • There are no current reports/presentations available.

  • 2021‑08‑11

    Half-yearly financial statements 2021

    PDF
    2021‑06‑28

    Annual financial statements 2020

    PDF

developCompany Presentation

  • There are no current reports/presentations available.

  • 2021‑11‑18

    9M Results Presentation

    PDF
    2021‑08‑11

    H1 Results Presentation

    PDF

developFinancial Calendar

  • Mar 30, 2022

    Annual Report 2021 + Earnings Call

    Apr 04, 2022

    CF&B SmallCap Event (April 4 - 5, 2022)
    Paris

    May 03, 2022

    MKK – Münchner Kapitalmarkt Konferenz (May 3 - 4, 2022)
    Munich

    May 11, 2022

    Trading Update 3M/Q1 2022 + Earnings Call

    May 12, 2022

    Annual General Meeting

    May 18, 2022

    PLATOW Euro Finance Small Cap Conference
    Frankfurt (Main)

    August, 2022

    Half-year Report 2022 + Earnings Call

    Sep 05, 2022

    German Fall Conference (September 5 - 6, 2022)
    Frankfurt (Main)

    Oct 17, 2022

    CF&B European MidCap Event (October 17 - 18, 2022)
    Paris

    November, 2022

    Trading Update 9M/Q3 2022 + Earnings Call

    Nov 28, 2022

    EKF Deutsches Eigenkapitalforum (November 28 - 30, 2022)
    Frankfurt (Main)

  • February, 2021

    2020 Annual Report

    April, 2021

    Annual General Meeting 2021

    Jul 28, 2021

    Preliminary half-year figures

    Aug 11, 2021

    Publication of half-year financial statements / Conference call 14.00 CST

    Aug 26, 2021

    Hamburger Investorentag (HIT)
    Hamburg

    September, 2021

    Roadshow

    Sep 06, 2021

    Equity Forum German Fall Conference
    Frankfurt/Main

    Nov 18, 2021

    Quarterly Statement 9M 2021

    Nov 22, 2021

    German Equity Forum
    Frankfurt/Main

developManagers' Transactions

  • There are no current managers’ transactions available.
  • There are no current managers’ transactions available.

developOther mandatory notifications


There are no other mandatory notifications available.
CONTACT INVESTOR RELATIONS

We look forward to your message

Do not miss any publications or news about APONTIS PHARMA AG. By registering for our IR mailings, you will always stay informed.